Cargando…

Vitamin D Increases CTLA-4 Gene Expression in Patients with Mild to Moderate Ulcerative Colitis

BACKGROUND Ulcerative colitis (UC) is a chronic inflammatory disorder of the large intestine. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a member of the immunoglobulin superfamily, which binds B7-1 and B7-2 on APCs (antigen-presenting cells), and induces APCs to produce an inhibitory si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharifi, Amrollah, Vahedi, Homayoon, Honarvar, Mohammad Reza, Alipoor, Behnam, Nikniaz, Zeinab, Rafiei, Hossein, Hosseinzadeh-Attar, Mohammad Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895856/ https://www.ncbi.nlm.nih.gov/pubmed/31824622 http://dx.doi.org/10.15171/mejdd.2019.149

Ejemplares similares

Vitamin D Status and Its Relation to Inflammatory Markers in Patients with Mild to Moderate Ulcerative Colitis
por: Sharifi, Amrollah, et al.
Publicado: (2018)

A Randomized Controlled Trial on the Effect of Vitamin D3 on Inflammation and Cathelicidin Gene Expression in Ulcerative Colitis Patients
por: Sharifi, Amrollah, et al.
Publicado: (2016)

Pulmonary Function and Methacholine Challenge Tests in Patients with Ulcerative Colitis
por: Taherzadeh, Maryam, et al.
Publicado: (2012)

Report of a Rare Case of Nasal Mucosa Pyoderma Vegetans in a Patient with Ulcerative Colitis
por: Vahedi, Homayoon, et al.
Publicado: (2015)

Relationship between Microalbuminuria and Disease Activity in Patients with Ulcerative Colitis
por: Masnadi Shirazi, Kourosh, et al.
Publicado: (2020)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
por: Kedia, Prashant, et al.
Publicado: (2007)

Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis
por: Kruis, Wolfgang, et al.
Publicado: (2023)

Health-Related Quality of Life in Chinese Patients with Mild and Moderately Active Ulcerative Colitis
por: Zheng, Kai, et al.
Publicado: (2015)

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
por: Caron, Bénédicte, et al.
Publicado: (2022)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs
por: Tindall, William N., et al.
Publicado: (2007)

Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
por: Awadhi, Sameer Al, et al.
Publicado: (2023)

Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey
por: Hébuterne, Xavier, et al.
Publicado: (2023)

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
por: Caron, Bénédicte, et al.
Publicado: (2023)

Multiple sclerosis and ulcerative colitis: A systematic review and meta-analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
por: Cheon, Jae Hee, et al.
Publicado: (2023)

Impaired Butyrate Induced Regulation of T Cell Surface Expression of CTLA-4 in Patients with Ulcerative Colitis
por: Magnusson, Maria K., et al.
Publicado: (2021)

Effect of Soymilk Consumption on Waist Circumference and Cardiovascular Risks among Overweight and Obese Female Adults
por: Keshavarz, Seyed Ali, et al.
Publicado: (2012)

Effect of fish oil on circulating asymmetric dimethylarginine and adiponectin in overweight or obese patients with atrial fibrillation
por: Khorrami, Elnaz, et al.
Publicado: (2020)

Combined Diosmectite and Mesalazine Treatment for Mild-to-Moderate Ulcerative Colitis: A Randomized, Placebo-Controlled Study
por: Jiang, Xue-Liang, et al.
Publicado: (2015)

High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis
por: Winter, Harland S., et al.
Publicado: (2014)

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
por: Jeon, Seong Ran
Publicado: (2018)

Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010–2014
por: Akhuemonkhan, Eboselume, et al.
Publicado: (2017)

The Efficacy and Safety of Mesalamine and Probiotics in Mild-to-Moderate Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Tian, Chunying, et al.
Publicado: (2020)

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
por: Panes, Julian, et al.
Publicado: (2023)

Effect of Collagen Hydrolysate and Fish Oil on High-Sensitivity C-Reactive Protein and Glucose Homeostasis in Patients with severe Burn; a Randomized Clinical Trial
por: Alipoor, Elham, et al.
Publicado: (2021)

Dietary protein intakes and risk of ulcerative colitis
por: Rashvand, Samaneh, et al.
Publicado: (2015)

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T., et al.
Publicado: (2017)

Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
por: Bernerth, Karsten, et al.
Publicado: (2018)

Diagnostic Value of Fecal Calprotectin in Patient with Ulcerative Colitis
por: Zamani, Hamed, et al.
Publicado: (2013)

Tracheal stenosis following mild-to-moderate COVID-19 infection without history of tracheal intubation: a case report
por: Ershadi, Reza, et al.
Publicado: (2021)

Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial
por: Sadeghi, Omid, et al.
Publicado: (2020)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
por: Travis, Simon P L, et al.
Publicado: (2014)

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T, et al.
Publicado: (2017)

Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials
por: Shen, Zhaofeng, et al.
Publicado: (2019)

Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nhpi65lc3dcknck92ge59gr5ft